References
- Brasch R. Rationale and applications for macromolecular Gd-based contrast agents. Magn Reson Med 1991; 22: 282–7
- Lai P., Yang C., Pan H., Wu M., Chu S., Ger L., et al. Recurrent inverted papilloma: diagnosis with pharmacokinetic dynamic gadolinium-enhanced MR imaging. Am J Neuroradiol 1999; 20: 1445–51
- Dyke J., Panicek D., Healey J., Meyers P., Huvos A., Schwartz L., et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast enhanced MR imaging. Radiology 2003; 228: 271–8
- Sinha S., Bastin M., Whittle I., Wardlaw J. Diffusion tensor MR imaging of high-grade cerebral gliomas. Am J Neuroradiol 2002; 23: 520–7
- Lang P., Wendland M. F., Saeed M., Blake M., DiMasi M., Eustace S. Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion weighted MR imaging. Radiology 1998; 206: 227–35
- Abdel Razek A., Kandeel A., Soliman N., El-shenshawy H., Kamel Y., Nada N., et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. Am J Neuroradiol 2007; 28: 1146–52
- Baur A., Huber A., Arbogast S., Durr H., Zysk S., Wendtner C., et al. Diffusion-weighted imaging of tumor recurrences and posttherapeutical soft-tissue changes in humans. Eur Radiol 2001; 11: 828–33
- Roth Y., Tichler T., Kostenich G., Ruiz-Cabello J., Maier S., Cohen J., et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004; 232: 685–92
- Thoeny H. C., Keyzer F., Chen F., Ni Y., Landuyt W., Verbeken E., et al. Diffusion-weighted MR Imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats. Radiology 2005; 234: 756–64
- Thoeny H., Keyzer F. Extracranial applications of diffusion-weighted magnetic resonance imaging. Eur Radiol 2007; 17: 1385–93
- Koh D., Collins D. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 2007; 88: 1622–35
- Gray L., MacFall J. Overview of diffusion imaging. Magn Reson Imaging Clin North Amer 1998; 6: 125–38
- Wang J., Takashima S., Takayama F., Kawajami S., Saito A., Matsushita T., et al. Head and neck lesions: characterization with diffusion-weighted echoplanar MR imaging. Radiology 2001; 220: 621–30
- Abdel Razek A., Soliman N., Elkhammary S., Elsharawey K., Tawfik A. Role of diffusion-weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006; 16: 1468–77
- Eida S., Sumi M., Sakihama N., Takahashi H., Nakamura H. Apparent diffusion coefficient mapping of salivary gland tumors: prediction of the benignancy and malignancy. Am J Neuroradiol 2007; 28: 116–21
- Sumi M., Sakihama N., Sumi T., Morikawa M., Uetani M., Kabasawa H., et al. Discrimination of metastatic lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 2003; 24: 1627–34
- Hermans R., Pameijer F., Mancousa A., Parsons J., Mendenhll W. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow up CT after definite irradiation therapy be used to detect local failure earlier than clinical examination alone?. Radiology 2000; 214: 683–7
- Nomayr A., Lell M., Sweeney R., Bautz W., Lukas P. MRI appearance of irradiation-induced changes of normal cervical tissues. Eur Radiol 2001; 11: 1807–17